Intercell Announces First Subject Enrolled in a Phase II Trial for the further development of its Vaccine Enhancement Patch
Phase II clinical trial investigating the effectiveness of Intercell’s Vaccine Enhancement (VE) Patch in combination with an injectable H5N1 pandemic influenza vaccine
02-Jun-2009 -
Intercell AG announced that it has advanced its efforts to develop its VE Patch to improve prevention of H5N1 pandemic influenza with the start of a Phase II clinical trial. The randomized and blinded study aims to determine the optimal dosage of both Intercell’s VE Patch and the H5N1 influenza ...
clinical trials
Intercell
Netherlands
+2